David McCollum

2.5k total citations · 2 hit papers
26 papers, 1.9k citations indexed

About

David McCollum is a scholar working on Surgery, Internal Medicine and Oncology. According to data from OpenAlex, David McCollum has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 9 papers in Internal Medicine and 8 papers in Oncology. Recurrent topics in David McCollum's work include Heparin-Induced Thrombocytopenia and Thrombosis (11 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). David McCollum is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (11 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). David McCollum collaborates with scholars based in United States and United Kingdom. David McCollum's co-authors include David R. Spigel, Marcie J. Hursting, Allen Lee Cohn, Tarek Chidiac, Christopher Hagenstad, Rafael G. Amado, Robert G Deeter, Edith P. Mitchell, Seta Shahin and John L. Marshall and has published in prestigious journals such as Journal of Clinical Oncology, Blood and CHEST Journal.

In The Last Decade

David McCollum

26 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations

2008 661 citations Lecia V. Sequist, Renato Martins et al. Journal of Clinical Oncology profile →
A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer

2008 644 citations David R. Spigel, David McCollum et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David McCollum United States	14	1.1k	912	438	381	238	26	1.9k
Abdel Hmissi Switzerland	17	2.7k 2.5×	900 1.0×	901 2.1×	549 1.4×	155 0.7×	34	4.1k
Tomomi Kamba Japan	27	1.0k 1.0×	1.2k 1.3×	371 0.8×	1.3k 3.5×	635 2.7×	152	3.3k
Isamu Makino Japan	23	711 0.7×	470 0.5×	585 1.3×	363 1.0×	154 0.6×	136	1.6k
Judith A.M. Wessels Netherlands	23	338 0.3×	248 0.3×	178 0.4×	446 1.2×	138 0.6×	43	2.0k
Hirohisa Kitagawa Japan	29	1.9k 1.7×	873 1.0×	1.2k 2.7×	428 1.1×	511 2.1×	132	2.9k
Hironori Hayashi Japan	22	442 0.4×	235 0.3×	341 0.8×	305 0.8×	136 0.6×	97	1.2k
Shinji Sumiyoshi Japan	21	484 0.5×	734 0.8×	390 0.9×	446 1.2×	249 1.0×	60	1.8k
Laura W. Goff United States	21	1.0k 0.9×	432 0.5×	526 1.2×	742 1.9×	326 1.4×	77	2.0k
Marius C. van den Heuvel Netherlands	18	156 0.1×	208 0.2×	504 1.2×	236 0.6×	89 0.4×	59	1.2k
Wilfried J. Graveland Netherlands	21	822 0.8×	533 0.6×	189 0.4×	380 1.0×	145 0.6×	27	1.7k

Countries citing papers authored by David McCollum

Since Specialization

Citations

This map shows the geographic impact of David McCollum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McCollum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McCollum more than expected).

Fields of papers citing papers by David McCollum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David McCollum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McCollum. The network helps show where David McCollum may publish in the future.

Co-authorship network of co-authors of David McCollum

This figure shows the co-authorship network connecting the top 25 collaborators of David McCollum. A scholar is included among the top collaborators of David McCollum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David McCollum. David McCollum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weir, Matthew R., Thomas C. Pearson, Anita Patel, et al.. (2016). Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. Transplantation. 101(1). 157–165. 12 indexed citations

Cartwright, Thomas H., David McCollum, & Kristi A. Boehm. (2010). Dosing Considerations for Capecitabine-Irinotecan Regimens in the Treatment of Metastatic and/or Locally Advanced Colorectal Cancer. American Journal of Clinical Oncology. 33(3). 307–313. 3 indexed citations

Sequist, Lecia V., Renato Martins, David R. Spigel, et al.. (2008). First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations. Journal of Clinical Oncology. 26(15). 2442–2449. 661 indexed citations breakdown →

Rice, Lawrence, Marcie J. Hursting, G. Mark Baillie, & David McCollum. (2007). Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin‐induced Thrombocytopenia. The Journal of Clinical Pharmacology. 47(8). 1028–1034. 21 indexed citations

Sequist, Lecia V., Renato Martins, David R. Spigel, et al.. (2007). iTARGET: A phase II trial to assess the response to gefitinib in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) tumors. Journal of Clinical Oncology. 25(18_suppl). 7504–7504. 21 indexed citations

Jang, Ik‐Kyung, Marcie J. Hursting, & David McCollum. (2007). Argatroban Therapy in Patients with Coronary Artery Disease and Heparin-Induced Thrombocytopenia. Cardiology. 109(3). 172–176. 10 indexed citations

Richards, Donald, David McCollum, Lalan S. Wilfong, et al.. (2007). Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction. Annals of Oncology. 19(1). 104–108. 28 indexed citations

Riha, Penny D., et al.. (2007). The brain metabolic enhancer methylene blue improves discrimination learning in rats. Pharmacology Biochemistry and Behavior. 86(4). 712–717. 50 indexed citations

Richards, Donald, Lalan S. Wilfong, David McCollum, et al.. (2006). Phase II multicenter trial of docetaxel+oxaliplatin in stage IV gastroesophageal and/or stomach cancer. Journal of Clinical Oncology. 24(18_suppl). 4071–4071. 6 indexed citations

10.

Levine, Robert L., David McCollum, & Marcie J. Hursting. (2006). How Frequently Is Venous Thromboembolism in Heparin-Treated Patients Associated With Heparin-Induced Thrombocytopenia?. CHEST Journal. 130(3). 681–687. 21 indexed citations

11.

Guzzi, Louis M., David McCollum, & Marcie J. Hursting. (2006). Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia. Journal of Thrombosis and Thrombolysis. 22(3). 169–176. 35 indexed citations

12.

Levine, Robert L., Marcie J. Hursting, & David McCollum. (2006). Argatroban Therapy in Heparin-Induced Thrombocytopenia With Hepatic Dysfunction. CHEST Journal. 129(5). 1167–1175. 65 indexed citations

13.

Guzzi, Louis M., David McCollum, & Marcie J. Hursting. (2006). EFFECT OF RENAL FUNCTION ON ARGATROBAN THERAPY IN HEPARIN-INDUCED THROMBOCYTOPENIA.. Critical Care Medicine. 34. A73–A73. 3 indexed citations

14.

Greenberg, Barry, Mandeep R. Mehra, John R. Teerlink, et al.. (2006). COMPARE: Comparison of the Effects of Carvedilol CR and Carvedilol IR on Left Ventricular Ejection Fraction in Patients with Heart Failure. The American Journal of Cardiology. 98(7). 53–59. 9 indexed citations

15.

Begelman, Susan M., Marcie J. Hursting, Richard V. Aghababian, & David McCollum. (2005). Heparin‐induced thrombocytopenia from venous thromboembolism treatment. Journal of Internal Medicine. 258(6). 563–572. 10 indexed citations

16.

Begelman, Susan M., Marcie J. Hursting, Richard V. Aghababian, & David McCollum. (2005). Heparin-Induced Thrombocytopenia from Venous Thromboembolism Treatment.. Blood. 106(11). 908–908. 1 indexed citations

17.

Irish, William, David McCollum, Raymond J. Tesi, et al.. (2003). Nomogram for Predicting the Likelihood of Delayed Graft Function in Adult Cadaveric Renal Transplant Recipients. Journal of the American Society of Nephrology. 14(11). 2967–2974. 174 indexed citations

18.

El‐Sabrout, Rafik, et al.. (2003). Improved freedom from rejection after a loading dose of sirolimus. Transplantation. 75(1). 86–90. 14 indexed citations

19.

El‐Sabrout, Rafik, et al.. (2002). African American and Caucasian Renal Transplant Recipients Have Equal Acute Rejection Rates under Sirolimus and Tacrolimus Combination Therapy. 5(8). 455–461. 3 indexed citations

20.

Riha, Penny D., et al.. (2002). Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neuroscience Letters. 332(2). 83–86. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact